CHAQ
Chardan Healthcare Acquisition 2 Corp.
Set alert
8.41 0.00 0.00%
8.10 Day range 9.25
8.06 52-week range 11.12
- Open
- 9.35
- Prev close
- 8.41
- Mkt cap
- 90.65M
- Vol
- 242.66K
- Avg vol
- 44.72K
- EPS
- -0.061
- P/E
- -137.87
- Div yield
- 0.00%
More statistics
- Low
- 8.10
- High
- 9.25
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.34
- Inst. own
- 58.73%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 9.92
- 200-d avg
- 10.04
- 1y target
- 0.00
Key statistics
- Market cap
- 90.65M
- Enterprise value
- 90.84M
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- -0.061
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 304.57K
- Total debt
- 500.00K
- Return on equity
- 0.00%
- Shares outstanding
- 10.78M
- Short % of float
- 0.09%
- 50-day average
- 9.92
- 200-day average
- 10.04
Analyst view
Consensus: none
Price target (mean) 0.00
Next earnings
Consensus EPS estimate 0.00.
About Chardan Healthcare Acquisition 2 Corp.
Chardan Healthcare Acquisition 2 Corp. does not have significant operations. It intends to acquire assets and businesses through a merger, share exchange, stock purchase, recapitalization, reorganization, or other similar business combination. The company was incorporated in 2018 and is based in New York, New York.
- Sector
- Financial Services
- Industry
- Shell Companies
- Country
- United States
- Website
- chardanhealthcarespac.com
News
- Renovacor, Inc. Closes Its Business Combination with Chardan Healthcare Acquisition 2 Corp. and Will Begin Trading on the New York Stock Exchange
- Chardan Healthcare Acquisition 2 Corp. Announces Stockholder Approval Of Business Combination With Renovacor, Inc.
- Chardan Healthcare Acquisition 2 Corp. Announces Renovacor's Appointment of Matt Killeen, Ph.D., as Chief Scientific Officer
- Renovacor Announces the Appointment of Jiwen Zhang, Ph.D., as Senior Vice President, Regulatory Affairs and Quality Assurance
- SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Chardan Healthcare Acquisition 2 Corp. - CHAQ
- U.S. IPO Weekly Recap: Solar Technology Shines In A 9-IPO Week
- U.S. IPO Weekly Recap: Health And Tech Dominate The Calendar In An 11 IPO Week
- Kamada Ltd. (KMDA) Q2 2019 Earnings Call Transcript | The Motley Fool
Your note
Sign in to keep a note on CHAQ — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| RTW Investments LP | 7.77% | 837,540 | 8.42M | Mar 30, 2021 |
| Altium Capital Management, LP | 6.99% | 753,374 | 7.57M | Mar 30, 2021 |
| Periscope Capital Inc. | 5.57% | 600,500 | 6.04M | Mar 30, 2021 |
| Sio Capital Management, LLC | 5.57% | 600,000 | 6.03M | Mar 30, 2021 |
| 683 Capital Management LLC | 3.25% | 350,000 | 3.52M | Mar 30, 2021 |
| K2 Principal Fund, L.P. | 2.91% | 313,443 | 3.15M | Mar 30, 2021 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| RiverNorth Opportunities Fd | 0.28% | 29,794 | 301.51K | Apr 29, 2021 |
| Investment Managers Ser Tr II-Vivaldi Multi-Strategy Fd | 0.04% | 3,962 | 39.82K | Mar 30, 2021 |
| The Relative Value Fund | 0.02% | 1,662 | 16.70K | Mar 30, 2021 |